harmaline has been researched along with 1-methyl-beta-carboline-3-carboxylic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, JK; Dan, WJ; Wan, JB | 1 |
| Bonetti, EP; Burkard, WP; Haefely, W | 1 |
1 review(s) available for harmaline and 1-methyl-beta-carboline-3-carboxylic acid
| Article | Year |
|---|---|
Natural and synthetic β-carboline as a privileged antifungal scaffolds.
Topics: Animals; Antifungal Agents; Biological Products; Carbolines; Drug Discovery; Female; Humans; Male; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycoses; Protein Binding; Signal Transduction; Structure-Activity Relationship | 2022 |
1 other study(ies) available for harmaline and 1-methyl-beta-carboline-3-carboxylic acid
| Article | Year |
|---|---|
The benzodiazepine antagonist Ro 15-1788 reverses the effect of methyl-beta-carboline-3-carboxylate but not of harmaline on cerebellar cGMP and motor performance in mice.
Topics: Alkaloids; Animals; Benzodiazepines; Benzodiazepinones; Carbolines; Cerebellum; Cyclic GMP; Flumazenil; Harmaline; Indoles; Male; Mice; Mice, Inbred Strains; Motor Activity; Receptors, GABA-A | 1985 |